SCHEDULE: 60 Degrees Pharmaceuticals Stake Grows to 9.1%

Intracoastal Capital LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, reported beneficial ownership of 263,158 shares, representing 9.1% of 60 Degrees Pharmaceuticals, Inc. common stock.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC have collectively reported beneficial ownership of 263,158 shares of 60 Degrees Pharmaceuticals, Inc. common stock.
• This holding represents approximately 9.1% of the company's outstanding common stock as of March 31, 2026.
• The reported shares are primarily issuable upon the exercise of two warrants held by Intracoastal Capital LLC.
• The filing also notes that certain other warrants held by Intracoastal Capital LLC contain 'blocker provisions' that limit the exercise of shares to maintain beneficial ownership below 4.99%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on existing beneficial ownership derived from warrants and acknowledging limitations on further exercise due to blocker provisions.

Positives

• Increased stake in 60 Degrees Pharmaceuticals, Inc. to 9.1% by reporting persons.
• The reporting persons hold warrants that provide potential for future share acquisition.

Negatives

• The beneficial ownership is primarily derived from warrants, not directly owned shares.
• Significant portions of potential share acquisition are limited by 'blocker provisions' in several warrants, preventing the full exercise of these instruments.

Risks

• The 'blocker provisions' in multiple warrants (Warrants 3, 4, 5, 6, and 7) restrict the ability to exercise them, limiting the potential increase in beneficial ownership.
• The reliance on warrant exercise for beneficial ownership means the actual voting and dispositive power is contingent on warrant terms and potential future decisions.

Future Outlook

The filing does not contain forward-looking statements or guidance. The beneficial ownership is based on existing warrants and outstanding shares as of a specific date.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing indicates a significant passive investment by Intracoastal Capital LLC and associated individuals in 60 Degrees Pharmaceuticals, Inc. The use of warrants and blocker provisions is a common strategy in venture capital and activist investing to manage ownership levels and potential future influence.

Stakeholder Impact

• Shareholders: The increased stake by a single entity to 9.1% could be perceived as a sign of confidence or potential future influence, though the passive nature of the filing and warrant limitations temper this.
• Management: May need to monitor the intentions of the reporting persons, especially if their stake were to approach levels that trigger control considerations.

Next Steps

• The reporting persons may continue to hold or exercise their warrants, subject to the terms and blocker provisions.
• Further filings would be required if beneficial ownership changes significantly.

Key Dates

Keywords

Schedule 13G, 60 Degrees Pharmaceuticals, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Beneficial Ownership, Warrants, Blocker Provisions, SEC Filing, Common Stock